Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 715

1.

Reducing Variation in the "Standard of Care" for Cancer Screening: Recommendations From the PROSPR Consortium.

Corley DA, Haas JS, Kobrin S.

JAMA. 2016 May 17;315(19):2067-8. doi: 10.1001/jama.2016.3067. No abstract available.

2.

Estrogen Receptor Status Predicts Late-Onset Skeletal Recurrence in Breast Cancer Patients.

Han HH, Lee SH, Kim BG, Lee JH, Kang S, Cho NH.

Medicine (Baltimore). 2016 Feb;95(8):e2909. doi: 10.1097/MD.0000000000002909.

3.

Impact of Early Breast Cancer Screening on Mortality Among Young Survivors of Childhood Hodgkin's Lymphoma.

Hodgson DC, Cotton C, Crystal P, Nathan PC.

J Natl Cancer Inst. 2016 Mar 1;108(7). pii: djw010. doi: 10.1093/jnci/djw010. Print 2016 Jul. Erratum in: J Natl Cancer Inst. 2016 Apr;108(4). pii: djw102. doi: 10.1093/jnci/djw102.

PMID:
26933010
4.

Contribution of mammography to MRI screening in BRCA mutation carriers by BRCA status and age: individual patient data meta-analysis.

Phi XA, Saadatmand S, De Bock GH, Warner E, Sardanelli F, Leach MO, Riedl CC, Trop I, Hooning MJ, Mandel R, Santoro F, Kwan-Lim G, Helbich TH, Tilanus-Linthorst MM, van den Heuvel ER, Houssami N.

Br J Cancer. 2016 Mar 15;114(6):631-7. doi: 10.1038/bjc.2016.32. Epub 2016 Feb 23.

PMID:
26908327
5.

Magnetic Resonance Imaging after Completion of Neoadjuvant Chemotherapy Can Accurately Discriminate between No Residual Carcinoma and Residual Ductal Carcinoma In Situ in Patients with Triple-Negative Breast Cancer.

Park S, Yoon JH, Sohn J, Park HS, Moon HJ, Kim MJ, Kim EK, Kim SI, Park BW.

PLoS One. 2016 Feb 11;11(2):e0149347. doi: 10.1371/journal.pone.0149347. eCollection 2016.

6.

Imaging and Data Acquisition in Clinical Trials for Radiation Therapy.

FitzGerald TJ, Bishop-Jodoin M, Followill DS, Galvin J, Knopp MV, Michalski JM, Rosen MA, Bradley JD, Shankar LK, Laurie F, Cicchetti MG, Moni J, Coleman CN, Deye JA, Capala J, Vikram B.

Int J Radiat Oncol Biol Phys. 2016 Feb 1;94(2):404-11. doi: 10.1016/j.ijrobp.2015.10.028. Epub 2015 Oct 24. Review.

PMID:
26853346
7.

A monoclonal antibody against KCNK9 K(+) channel extracellular domain inhibits tumour growth and metastasis.

Sun H, Luo L, Lal B, Ma X, Chen L, Hann CL, Fulton AM, Leahy DJ, Laterra J, Li M.

Nat Commun. 2016 Feb 4;7:10339. doi: 10.1038/ncomms10339.

8.

Integrated nanotechnology platform for tumor-targeted multimodal imaging and therapeutic cargo release.

Hosoya H, Dobroff AS, Driessen WH, Cristini V, Brinker LM, Staquicini FI, Cardó-Vila M, D'Angelo S, Ferrara F, Proneth B, Lin YS, Dunphy DR, Dogra P, Melancon MP, Stafford RJ, Miyazono K, Gelovani JG, Kataoka K, Brinker CJ, Sidman RL, Arap W, Pasqualini R.

Proc Natl Acad Sci U S A. 2016 Feb 16;113(7):1877-82. doi: 10.1073/pnas.1525796113. Epub 2016 Feb 2.

9.

Imaging Diagnostic and Therapeutic Targets: Steroid Receptors in Breast Cancer.

Fowler AM, Clark AS, Katzenellenbogen JA, Linden HM, Dehdashti F.

J Nucl Med. 2016 Feb;57 Suppl 1:75S-80S. doi: 10.2967/jnumed.115.157933. Review.

10.

Mouse Models of Breast Cancer: Platforms for Discovering Precision Imaging Diagnostics and Future Cancer Medicine.

Manning HC, Buck JR, Cook RS.

J Nucl Med. 2016 Feb;57 Suppl 1:60S-8S. doi: 10.2967/jnumed.115.157917. Review.

PMID:
26834104
11.

Quo Vadis: PET and Single-Photon Molecular Breast Imaging.

Wahl RL.

J Nucl Med. 2016 Feb;57 Suppl 1:3S-8S. doi: 10.2967/jnumed.115.159202. Review. No abstract available.

PMID:
26834100
12.

Immunological Characterization of Whole Tumour Lysate-Loaded Dendritic Cells for Cancer Immunotherapy.

Rainone V, Martelli C, Ottobrini L, Biasin M, Texido G, Degrassi A, Borelli M, Lucignani G, Trabattoni D, Clerici M.

PLoS One. 2016 Jan 21;11(1):e0146622. doi: 10.1371/journal.pone.0146622. eCollection 2016. Erratum in: PLoS One. 2016;11(3):e0151008. Texido, Gemma [added]; Degrassi, Anna [added].

13.

No strong evidence for increased risk of breast cancer 8-26 years after multiple mammograms in their 30s in females at moderate and high familial risk.

Evans DG, Kotre CJ, Harkness E, Wilson M, Maxwell AJ, Howell A.

Br J Radiol. 2016;89(1059):20150960. doi: 10.1259/bjr.20150960. Epub 2016 Jan 21.

PMID:
26795734
14.

A Public Health Framework for Screening Mammography: Evidence-Based vs Politically Mandated Care.

Lin KW, Gostin LO.

JAMA. 2016 Mar 8;315(10):977-8. doi: 10.1001/jama.2016.0322. No abstract available.

PMID:
26779886
15.

Identification of p62/SQSTM1 as a component of non-canonical Wnt VANGL2-JNK signalling in breast cancer.

Puvirajesinghe TM, Bertucci F, Jain A, Scerbo P, Belotti E, Audebert S, Sebbagh M, Lopez M, Brech A, Finetti P, Charafe-Jauffret E, Chaffanet M, Castellano R, Restouin A, Marchetto S, Collette Y, Gonçalvès A, Macara I, Birnbaum D, Kodjabachian L, Johansen T, Borg JP.

Nat Commun. 2016 Jan 12;7:10318. doi: 10.1038/ncomms10318.

16.

Validation of the IHC4 Breast Cancer Prognostic Algorithm Using Multiple Approaches on the Multinational TEAM Clinical Trial.

Bartlett JM, Christiansen J, Gustavson M, Rimm DL, Piper T, van de Velde CJ, Hasenburg A, Kieback DG, Putter H, Markopoulos CJ, Dirix LY, Seynaeve C, Rea DW.

Arch Pathol Lab Med. 2016 Jan;140(1):66-74. doi: 10.5858/arpa.2014-0599-OA.

PMID:
26717057
17.

Disparities in the use of screening magnetic resonance imaging of the breast in community practice by race, ethnicity, and socioeconomic status.

Haas JS, Hill DA, Wellman RD, Hubbard RA, Lee CI, Wernli KJ, Stout NK, Tosteson AN, Henderson LM, Alford-Teaster JA, Onega TL.

Cancer. 2016 Feb 15;122(4):611-7. doi: 10.1002/cncr.29805. Epub 2015 Dec 28.

PMID:
26709819
18.

Response to Letter Regarding the Impact of U.S. Preventive Services Task Force Recommendations in Breast Cancer Screening Trends.

Dehkordy SF, Hall KS, Roach AL, Rothman ED, Dalton VK, Carlos RC.

Am J Prev Med. 2016 Jan;50(1):e31. doi: 10.1016/j.amepre.2015.09.031. No abstract available.

PMID:
26706258
19.

Concordance of BI-RADS Assessments and Management Recommendations for Breast MRI in Community Practice.

Lee AY, Ichikawa L, Lee JM, Lee CI, DeMartini WB, Joe BN, Wernli KJ, Sprague BL, Herschorn SD, Lehman CD.

AJR Am J Roentgenol. 2016 Jan;206(1):211-6. doi: 10.2214/AJR.15.14356.

PMID:
26700354
20.

Associations Between Elastography Findings and Clinicopathological Factors in Breast Cancer.

Hayashi M, Yamamoto Y, Sueta A, Tomiguchi M, Yamamoto-Ibusuki M, Kawasoe T, Hamada A, Iwase H.

Medicine (Baltimore). 2015 Dec;94(50):e2290. doi: 10.1097/MD.0000000000002290.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk